Kalshi to offer bets on drug trial results and FDA regulatory decisions
Prediction market platform Kalshi is expanding into bets on clinical trial outcomes and FDA regulatory decisions, and is considering adding contracts on flight delays. The company argues that publicly listed drug-trial contracts will produce continuously updated, independent probabilities — free from trial sponsors' preferred messaging. Prediction platforms are rapidly gaining popularity, offering wagers on virtually any event.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!